Rosenblatt Maintains Buy on Imax, Raises Price Target to $30
Portfolio Pulse from richadhand@benzinga.com
Rosenblatt analyst Steve Frankel maintains a 'Buy' rating on Imax (NYSE:IMAX) and raises the price target from $27 to $30.
August 25, 2023 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel maintains a 'Buy' rating on Imax and raises the price target from $27 to $30.
The news of Rosenblatt analyst maintaining a 'Buy' rating and raising the price target for Imax is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100